
Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill Continues
来源:WSJ发布于 2026-11-04
The Danish drugmaker raised its guidance for the year after noting an improved outlook for its key obesity and diabetes drugs, particularly in markets outside of the U.S.
相关标的:NVO
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。